Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$1.46 - $2.45 $2.68 Million - $4.5 Million
-1,838,221 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$2.13 - $3.46 $786,768 - $1.28 Million
369,375 Added 25.15%
1,838,221 $4.28 Million
Q3 2021

Nov 09, 2021

BUY
$3.14 - $3.9 $1.11 Million - $1.38 Million
355,092 Added 31.88%
1,468,846 $5.11 Million
Q2 2021

Jul 20, 2021

SELL
$3.8 - $4.56 $86,605 - $103,926
-22,791 Reduced 2.01%
1,113,754 $4.32 Million
Q4 2020

Jan 22, 2021

BUY
$4.87 - $17.29 $3.34 Million - $11.9 Million
686,545 Added 152.57%
1,136,545 $6.88 Million
Q3 2020

Oct 19, 2020

BUY
$15.08 - $27.04 $6.79 Million - $12.2 Million
450,000 New
450,000 $7.4 Million

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $765M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.